Home
>
Sun Pharmaceuticals Industries Ltd Financials

Sun Pharmaceuticals Industries Ltd Financial Statement

Sun Pharmaceuticals Industries Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

(Rs. CR)	Dec 2023	Sep 2023	Jun 2023
Revenue	5,150.55	5,202.75	4,629.61
Operating Expense	3,784.56	3,709.89	3,666.52
Net Profit	721.31	888.63	380.64
Net Profit Margin	14	17.08	8.22
Earning Per Share	3	3.7	1.6
EBIDTA	1,365.99	1,492.86	963.09
Effective Tax Rate	2.21	1.2	0.96

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

5,150.55

3,784.56

721.31

1,365.99

2.21

5,202.75

3,709.89

888.63

17.08

3.7

1,492.86

1.2

4,629.61

3,666.52

380.64

8.22

1.6

963.09

0.96

Sun Pharmaceuticals Industries Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Total Revenue Annual	43,885.68	38,654.49	33,498.14
Operating Expenses Annual	32,112.79	28,410.73	25,030.42
Operating Profit Annual	12,109.86	6,752.41	5,020.75
Interest Annual	172	127.35	141.43
Depreciation	2,529.43	2,143.74	2,079.95
Net Profit Annual	8,473.58	3,272.73	2,903.82
Tax Annual	847.59	1,075.5	514.69

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

43,885.68

32,112.79

12,109.86

172

2,529.43

8,473.58

847.59

38,654.49

28,410.73

6,752.41

127.35

2,143.74

3,272.73

1,075.5

33,498.14

25,030.42

5,020.75

141.43

2,079.95

2,903.82

514.69

Sun Pharmaceuticals Industries Ltd Cash Flow

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Cash Flow at the Beginning	4,508.25	6,273.03	5,676.61
Cash Flow from Operations	4,959.33	8,984.54	6,170.37
Cash Flow from Investing	-7,219.92	-5,555.86	406.53
Cash Flow from Financing	2,376.07	-5,193.46	-5,980.48
Cash Flow at the End	4,623.73	4,508.25	6,273.03

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

4,508.25

4,959.33

-7,219.92

2,376.07

4,623.73

6,273.03

8,984.54

-5,555.86

-5,193.46

4,508.25

5,676.61

6,170.37

406.53

-5,980.48

6,273.03

Sun Pharmaceuticals Industries Ltd Key Ratios

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
PBDIT Margin (%)	27.59	29.19	27.8
PBIT Margin (%)	21.83	23.65	21.59
PBT Margin (%)	21.56	23.19	21.23
Net PROFIT Margin (%)	8.12	-0.64	5.97
Return On Networth / Equity (%)	16.46	14.5	11.14
Return On Networth /Employed(%)	16.79	17.97	13.6
Return On Assets (%)	5.93	-0.46	3.52
Total Debt / Equity(X)	0.27	0.24	0.27
Asset Turnover Ratio (%)	0.73	0.72	0.59

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

27.59

21.83

21.56

8.12

16.46

16.79

5.93

0.27

0.73

29.19

23.65

23.19

-0.64

14.5

17.97

-0.46

0.24

0.72

27.8

21.59

21.23

5.97

11.14

13.6

3.52

0.27

0.59

Sun Pharmaceuticals Industries Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Fixed Assets Annual	28,429.93	23,154.45	22,183.29
Total Current Assets Annual	39,861.94	34,864.6	30,442.08
Non Current Assets Annual	40,860.25	34,943.17	37,224.65
Total Shareholders Funds Annual	55,995.38	48,011.22	46,462.78
Total Assets Annual	80,743.59	69,807.77	67,666.73

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

28,429.93

39,861.94

40,860.25

55,995.38

80,743.59

23,154.45

34,864.6

34,943.17

48,011.22

69,807.77

22,183.29

30,442.08

37,224.65

46,462.78

67,666.73

Sun Pharmaceuticals Industries Ltd Earning Calls

Dec 2023

EPS beaten by -0.19 %

Open Demat Account

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

Get Your FAQs Right

What is Sun Pharmaceuticals Industries Ltd's share capital?

As of May 12, 2024, Sun Pharmaceuticals Industries Ltd has a market capitalization of 2,35,878.62 Cr. Value Research classifies it as a Mega-Cap company.

Is Sun Pharmaceuticals Industries Ltd debt-free?

Yes, Sun Pharmaceuticals Industries Ltd is debt-free with a debt-to-equity ratio of 0.12.

What is Sun Pharmaceuticals Industries Ltd's total revenue?

In FY 2023, Sun Pharmaceuticals Industries Ltd recorded a total revenue of approximately 43,278.87 Cr marking a significant milestone in the company's financial performance.

What is the future growth of Sun Pharmaceuticals Industries Ltd?

Sun Pharmaceuticals Industries Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.1% annually, respectively..

What is the PE Ratio of Sun Pharmaceuticals Industries Ltd?

Sun Pharmaceuticals Industries Ltd's current PE ratio is 27.84.

What is Sun Pharmaceuticals Industries Ltd's Return on Capital Employed (ROCE)?

Sun Pharmaceuticals Industries Ltd's ROCE averaged 15.9% from the FY ending March 2021 to 2023, with a median of 15.1%. It peaked at 18.4% in March 2022, reflecting strong capital efficiency over the period..

What is the latest EBIT (Earnings Before Interest and Taxes) of Sun Pharmaceuticals Industries Ltd?

Sun Pharmaceuticals Industries Ltd's latest EBIT is Rs. 9,580.43 Cr, surpassing the average EBIT of Rs. 5,709.97 Cr over the 5 years..